arthritis and musculoskeletal alliance

Live MatureMicroHealthy

arthritis and musculoskeletal alliance Company Information

Share ARTHRITIS AND MUSCULOSKELETAL ALLIANCE

Company Number

05380237

Shareholders

-

Group Structure

View All

Industry

Activities of professional membership organisations

 

Registered Address

international house, 109 - 111 fulham palace road, london, W6 8JA

arthritis and musculoskeletal alliance Estimated Valuation

£53.9k

Pomanda estimates the enterprise value of ARTHRITIS AND MUSCULOSKELETAL ALLIANCE at £53.9k based on a Turnover of £123.8k and 0.44x industry multiple (adjusted for size and gross margin).

arthritis and musculoskeletal alliance Estimated Valuation

£52.5k

Pomanda estimates the enterprise value of ARTHRITIS AND MUSCULOSKELETAL ALLIANCE at £52.5k based on an EBITDA of £22.6k and a 2.32x industry multiple (adjusted for size and gross margin).

arthritis and musculoskeletal alliance Estimated Valuation

£238.7k

Pomanda estimates the enterprise value of ARTHRITIS AND MUSCULOSKELETAL ALLIANCE at £238.7k based on Net Assets of £108.7k and 2.2x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Arthritis And Musculoskeletal Alliance Overview

Arthritis And Musculoskeletal Alliance is a live company located in london, W6 8JA with a Companies House number of 05380237. It operates in the activities of professional membership organizations sector, SIC Code 94120. Founded in March 2005, it's largest shareholder is unknown. Arthritis And Musculoskeletal Alliance is a mature, micro sized company, Pomanda has estimated its turnover at £123.8k with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Arthritis And Musculoskeletal Alliance Health Check

Pomanda's financial health check has awarded Arthritis And Musculoskeletal Alliance a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

5 Strong

positive_score

1 Regular

positive_score

5 Weak

size

Size

annual sales of £123.8k, make it smaller than the average company (£874.7k)

£123.8k - Arthritis And Musculoskeletal Alliance

£874.7k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 7%, show it is growing at a faster rate (4.8%)

7% - Arthritis And Musculoskeletal Alliance

4.8% - Industry AVG

production

Production

with a gross margin of 69.5%, this company has a comparable cost of product (69.5%)

69.5% - Arthritis And Musculoskeletal Alliance

69.5% - Industry AVG

profitability

Profitability

an operating margin of 17.9% make it more profitable than the average company (2.2%)

17.9% - Arthritis And Musculoskeletal Alliance

2.2% - Industry AVG

employees

Employees

with 2 employees, this is below the industry average (13)

2 - Arthritis And Musculoskeletal Alliance

13 - Industry AVG

paystructure

Pay Structure

on an average salary of £30.1k, the company has a lower pay structure (£47.7k)

£30.1k - Arthritis And Musculoskeletal Alliance

£47.7k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £61.9k, this is less efficient (£111.9k)

£61.9k - Arthritis And Musculoskeletal Alliance

£111.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 56 days, this is later than average (22 days)

56 days - Arthritis And Musculoskeletal Alliance

22 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 14 days, this is quicker than average (30 days)

14 days - Arthritis And Musculoskeletal Alliance

30 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Arthritis And Musculoskeletal Alliance

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 298 weeks, this is more cash available to meet short term requirements (101 weeks)

298 weeks - Arthritis And Musculoskeletal Alliance

101 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 14.6%, this is a lower level of debt than the average (26.4%)

14.6% - Arthritis And Musculoskeletal Alliance

26.4% - Industry AVG

ARTHRITIS AND MUSCULOSKELETAL ALLIANCE financials

EXPORTms excel logo

Arthritis And Musculoskeletal Alliance's latest turnover from December 2023 is £123.8 thousand and the company has net assets of £108.7 thousand. According to their latest financial statements, Arthritis And Musculoskeletal Alliance has 2 employees and maintains cash reserves of £106.6 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover123,780133,798107,430100,01091,73969,585120,534171,019110,618190,887177,210125,876124,267203,566169,497
Other Income Or Grants
Cost Of Sales37,70935,03427,22429,59629,59822,83038,85553,45937,55679,80679,47346,77448,05082,889
Gross Profit86,07198,76480,20670,41462,14146,75581,679117,56073,062111,08197,73779,10276,217120,677
Admin Expenses63,86051,47565,62858,46862,591103,907144,50771,45087,547100,13147,32282,042108,830182,631-27,685
Operating Profit22,21147,28914,57811,946-450-57,152-62,82846,110-14,48510,95050,415-2,940-32,613-61,95427,685
Interest Payable
Interest Receivable
Pre-Tax Profit20,71440,60511,9309,7301-56,586-62,24937,123-13,8269,17939,180-2,541-32,148-61,32920,201
Tax
Profit After Tax20,71440,60511,9309,7301-56,586-62,24937,123-13,8269,17939,180-2,541-32,148-61,32920,201
Dividends Paid
Retained Profit20,71440,60511,9309,7301-56,586-62,24937,123-13,8269,17939,180-2,541-32,148-61,32920,201
Employee Costs60,24754,40258,51656,83954,41453,82578,31373,74667,38086,87585,50575,48181,842122,62165,464
Number Of Employees222222433442232
EBITDA*22,59747,90314,80612,388-236-56,938-62,58446,620-13,97511,50250,787-1,856-31,740-61,08128,437

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets3867722284562144282447545322866588841,7571,502
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets3867722284562144282447545322866588841,7571,502
Stock & work in progress
Trade Debtors19,2651,71615,9073,50050032921,13524010,8612,50618,69816,43420,76134,215
Group Debtors
Misc Debtors9971,0148258258606801,7302,9804,7742,3925,2181,941
Cash106,56899,44762,86857,49574,32245,898105,060126,485108,432155,357112,23875,05484,594101,363148,616
misc current assets
total current assets126,830102,17779,60061,82075,68246,907106,790150,600113,446168,610119,96295,693101,028122,124182,831
total assets127,216102,94979,82862,27675,89647,335106,790150,844114,200169,142120,24896,351101,912123,881184,333
Bank overdraft
Bank loan
Trade Creditors 1,5101,1225462,4207241861,9531,0391,16636,9394977204,17010,01811,141
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities17,02913,86431,92424,42849,47421,45222,5545,2735,62510,9687,69522,75522,3256,2984,298
total current liabilities18,53914,98632,47026,84850,19821,63824,5076,3126,79147,9078,19223,47526,49516,31615,439
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities18,53914,98632,47026,84850,19821,63824,5076,3126,79147,9078,19223,47526,49516,31615,439
net assets108,67787,96347,35835,42825,69825,69782,283144,532107,409121,235112,05672,87675,417107,565168,894
total shareholders funds108,67787,96347,35835,42825,69825,69782,283144,532107,409121,235112,05672,87675,417107,565168,894
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit22,21147,28914,57811,946-450-57,152-62,82846,110-14,48510,95050,415-2,940-32,613-61,95427,685
Depreciation3866142284422142142445105105523721,084873873752
Amortisation
Tax
Stock
Debtors17,532-14,00212,4072,965351-721-22,38519,101-8,2395,529-12,9154,205-4,327-13,45434,215
Creditors388576-1,8741,696538-1,767914-127-35,77336,442-223-3,450-5,848-1,12311,141
Accruals and Deferred Income3,165-18,0607,496-25,04628,022-1,10217,281-352-5,3433,273-15,06043016,0272,0004,298
Deferred Taxes & Provisions
Cash flow from operations8,61844,4218,021-13,92727,973-59,086-22,00427,040-46,85245,68848,419-9,081-17,234-46,7509,661
Investing Activities
capital expenditure-1,158-684-642-732-798-858-1,128-2,254
Change in Investments
cash flow from investments-1,158-684-642-732-798-858-1,128-2,254
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue148,693
interest
cash flow from financing148,693
cash and cash equivalents
cash7,12136,5795,373-16,82728,424-59,162-21,42518,053-46,92543,11937,184-9,540-16,769-47,253148,616
overdraft
change in cash7,12136,5795,373-16,82728,424-59,162-21,42518,053-46,92543,11937,184-9,540-16,769-47,253148,616

arthritis and musculoskeletal alliance Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for arthritis and musculoskeletal alliance. Get real-time insights into arthritis and musculoskeletal alliance's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Arthritis And Musculoskeletal Alliance Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for arthritis and musculoskeletal alliance by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in W 6 area or any other competitors across 12 key performance metrics.

arthritis and musculoskeletal alliance Ownership

ARTHRITIS AND MUSCULOSKELETAL ALLIANCE group structure

Arthritis And Musculoskeletal Alliance has no subsidiary companies.

Ultimate parent company

ARTHRITIS AND MUSCULOSKELETAL ALLIANCE

05380237

ARTHRITIS AND MUSCULOSKELETAL ALLIANCE Shareholders

--

arthritis and musculoskeletal alliance directors

Arthritis And Musculoskeletal Alliance currently has 10 directors. The longest serving directors include Professor John Skinner (Oct 2018) and Ms Patricia North (Jul 2019).

officercountryagestartendrole
Professor John SkinnerEngland60 years Oct 2018- Director
Ms Patricia NorthEngland65 years Jul 2019- Director
Mr Huzefa VoraEngland51 years Jan 2020- Director
Mr Christopher MarteyEngland34 years Jul 2020- Director
Dr Jane TaylorEngland64 years Jul 2020- Director
Ms Sally PemberyEngland61 years Jul 2020- Director
Mrs Ruth SephtonEngland62 years Jul 2022- Director
Dr Dale WebbEngland55 years Jul 2022- Director
Mrs Debbie WilsonEngland45 years Jul 2022- Director
Ms Noha El AfifyEngland42 years Jul 2024- Director

P&L

December 2023

turnover

123.8k

-7%

operating profit

22.2k

0%

gross margin

69.6%

-5.8%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

108.7k

+0.24%

total assets

127.2k

+0.24%

cash

106.6k

+0.07%

net assets

Total assets minus all liabilities

arthritis and musculoskeletal alliance company details

company number

05380237

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

94120 - Activities of professional membership organisations

incorporation date

March 2005

age

20

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

December 2023

previous names

N/A

accountant

DAVID HOWARD

auditor

-

address

international house, 109 - 111 fulham palace road, london, W6 8JA

Bank

NATIONAL WESTMINSTER BANK PLC

Legal Advisor

-

arthritis and musculoskeletal alliance Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to arthritis and musculoskeletal alliance.

arthritis and musculoskeletal alliance Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ARTHRITIS AND MUSCULOSKELETAL ALLIANCE. This can take several minutes, an email will notify you when this has completed.

arthritis and musculoskeletal alliance Companies House Filings - See Documents

datedescriptionview/download